期刊文献+

annexin A2在人甲状腺癌中表达的意义 被引量:3

Expression of annexin A2 in human thyroid carcinoma
下载PDF
导出
摘要 目的观察annexin A2在甲状腺癌不同病理类型中的表达及其与临床病理指标的关系。方法采用免疫组化EnVision法,在24例甲状腺乳头状癌、25例甲状腺滤泡癌、22例甲状腺髓样癌及24例结节性甲状腺肿中检测annexin A2的表达。结果乳头状癌中annexinA2的阳性率为45.8%(11/24),明显高于滤泡癌、髓样癌和结节性甲状腺肿中的阳性率(4%、9.1%、8.3%)(P<0.05)。annexin A2的表达在结节性甲状腺肿与滤泡癌髓样癌及滤泡癌与髓样癌之间无显著差异。乳头状癌中,annexin A2的表达与性别、年龄、淋巴结转移及远处转移无关。结论在甲状腺乳头状癌中annexin A2过表达,提示其可能参与甲状腺乳头状癌的发病机制。 Objective To study the expression of annexin A2 in different types of thyroid carcinoma and its relation with chnicopathological features. Methods The expression of annexin A2 was detected in 24 cases of thyroid papillary carcinoma, 25 thyroid follicular carcinoma, 22 thyroid medullary carcinoma and 24 nodular goiter. The results were analyzed statistically. Results The positive rate of annexin A2 was 45.8% in papillary carcinoma, which was significantly higher than that in follicular carcinoma, medullary carcinoma and nodular goiter (4%, 9.1% and 8.3% respectively). No difference of the annexin A2 expression was observed among the follicular carcinoma, medullary carcinoma and nodular goiter. There was no apparent correlation between the expression level of annexin A2 and the chnicopathological features, such as age, gender, lymph node metastasis and distance metastasis. Conclusion annexin A2 is overexpressed in thyroid papillary carcinoma and it may play an important role in the carcinogenesis of thyroid papillary carcinoma.
出处 《诊断病理学杂志》 CSCD 2008年第2期117-120,共4页 Chinese Journal of Diagnostic Pathology
关键词 armexin A2 甲状腺乳头状癌 甲状腺滤泡癌 甲状腺髓样癌 annexin A2 Thyroid papillary carcinoma Thyroid follicular carcinoma Thyroid med,llary carcinoma
  • 相关文献

参考文献10

  • 1Emoto K Yamada Y, Sawada H, et al. Annexin Ⅱ overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma[J]. Cancer, 2001, 92(6) : 1419- 1426.
  • 2Chetcuti A, Margan SH, Russell P, et al. Loss of annexin Ⅱ heavy and light chains in prostate cancer and its precursors[J]. Cancer Res, 2001, 61(17): 6331-6334.
  • 3Zimmermann U, Woenckhaus C, Pietschmann S, et al. Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome[J]. Virchows Arch, 2004, 445.(4) :368 - 374.
  • 4Esposito I, Penzel R, Chaib-Harrireche M, et al. Tenasein C and annexin Ⅱ expression in the process of pancreatic carcinogenesis[J]. J Pathol, 2006, 208 (5) : 673 - 685.
  • 5Roseman B J, Bollen A, Hsu J, et al. Annexin Ⅱ marks astrocytic brain tumors of high histologic grade[J]. Oncol Res, 1994, 6(12) : 561 - 567.
  • 6张洵,支会英,张健,王秀琴,周传农,吴旻,孙耘田,刘芝华.钙磷脂结合蛋白Ⅱ在人食管鳞状细胞癌中的表达[J].中华肿瘤杂志,2003,25(4):353-355. 被引量:15
  • 7朱晓丽,周晓燕,朱雄增.甲状腺乳头状癌中BRAF^(V599E)点突变与RET/PTC融合基因的检测[J].中华病理学杂志,2005,34(5):270-274. 被引量:30
  • 8莫祥兰,黄振录,周祥祯,丁志敏,韦荣干,王国刚.TPO在甲状腺乳头状癌与乳头状增生鉴别诊断中的作用[J].诊断病理学杂志,2006,13(2):117-119. 被引量:11
  • 9Sharma MR, Koltowski L, Ownbey RT, et al. Angiogenesisassociated protein annexin Ⅱ in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression[J]. Exp Mol Pathol, 2006, 81(2) : 146- 156.
  • 10Musholt TJ, Hanack J, Brehm C, et al. Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression anlalysis by mRNA differential display [ J ]. World J Surg, 2005, 29 (4) :472 - 482.

二级参考文献41

  • 1Paweletz CP, Omstein DK, Roth MJ, et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.Cancer Res, 2000, 60:6293-6297.
  • 2Schwartz-Albiez R, Koretz K, Moiler P, et al. Differential expression of annexins I and Ⅱ in normal and malignant human mammary epithelial cells. Differentiation, 1993, 52:229-237.
  • 3Karimi-Busheri F, Marcoux Y, Tredget EE, et al. Expression of a releasable form of annexin Ⅱ by human keratinocytes. J cell Biochem,2002, 86:737-747.
  • 4Moss SE. Ion channels annexins taken to task. Nature, 1995, 378:446-447.
  • 5Ikeda G, Isaji S, Chandra B, et al. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer, 1999, 86:1396-1405.
  • 6Emoto K, Yamada Y, Sawada H, et al. Annexin Ⅱ overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer, 2001, 92:1419-1426.
  • 7Roseman BJ, Bollen A, Hsu J, et al. annexin Ⅱ marks astrocytic brain tumors of high histologic grade. Oncol Res, 1994, 6:561-567.
  • 8Vishwanatha JK, Chiang Y, Kumble KD, et al. Enhanced expression of annexin Ⅱ in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis, 1993, 14:2575-2579.
  • 9Cole SP, Pinkoski MJ, Bhardwaj G, et al. Elevated expression of annexin Ⅱ (lipocortin Ⅱ, p36) in a multidrug resistant small cell lung cancer cell line. Br J cancer, 1992, 65:498-502.
  • 10Chetcuti A, Margan SH, Russell P, et al. Loss of annexln Ⅱ heavy and light chains in prostate cancer and its precursors 1. Cancer Res, 2001,61:6331-6334.

共引文献53

同被引文献23

  • 1Andrade LJO, Melo PRS, Neto WA, et al, Molecular markers in thyroid cancer[J}. Revista Argentina de En- docriologiay Metabolismo, 2013,50 (2) ~ 84 89.
  • 2Harris PJ,Bible KC. Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches [J]. Expert Opin Investig Drugs, 2011, 20 (10): 1357- 1375.
  • 3Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [J]. CA Cancer J Clin,2010,60(5) :277-300.
  • 4Lee DB,Jamgotchian N, Allen SG, et al. Annexin A2 het- erotetramer., role in tight }unction assembly I-J}. Am J Physiol Renal Physiol, 2004,287 (3) : 481-491.
  • 5Bhaijee F, Nikiforov YE. Molecular analysis of thyroid tumors[J]. Endocr Pathol, 2011,22 (3) : 126 133.
  • 6Barollo S,Pennelli G, Vianello F, et al. BRAF in primary andreeurrent papillary thyroid cancers: the relationship with( 131 )Iand 2-E(18) F~ {luoro-2-deoxy-D-glucose up- take ability[J]. Eur J Endocrinol, 2010,163 (4) : 659-663.
  • 7Rescher U,Gerke V. Annexins-unique membrane binding proteins withdiverse functions[J]. J Cell Sci, 2004,117 (Pt 13) : 2631-2639.
  • 8Wang LP,Bi J,Yao C,et al. Annexin A1 expression and its prognostic significance in human breast cancer[J]. Neoplasma, 2010,57 (3) : 253-259.
  • 9Faria PC, Sena AA, Nascimento R, et al. Expression of annexin A1 mRNA in peripheral blood from oral squa- mous cell carcinoma patients[J]. Oral Oncol, 2010, 46 (I) :25-30.
  • 10Sehaeffer EM, Marehionni L, Huang Z, et al. Androgen- induced programs for prostate epithelial growth and inva- sion arise in embryogenesis and are reactivated in cancer [J]. Oncogene,2008,27(57) ~ 7180-7191.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部